Pharmaceutical price regulation and competition

 |  Login

Show simple item record

dc.contributor Aalto University en
dc.contributor Aalto-yliopisto fi
dc.contributor.author Skippari, Anneli
dc.date.accessioned 2013-06-25T07:15:52Z
dc.date.available 2013-06-25T07:15:52Z
dc.date.issued 2013
dc.identifier.uri https://aaltodoc.aalto.fi/handle/123456789/10283
dc.description.abstract OBJECTIVES Pharmaceutical price regulation has been widely implemented to most of the developed countries during the last 20 years. Price regulation has evoked strong debates because it is not clear whether it is necessary or not and, if necessary which tools to use and how should it be designed. In this thesis, I will conduct a literature review and analysis on how price regulation affects market prices and competition in the pharmaceutical industry. THEORETICAL FRAMEWORK The model of Brekke, Grasdal and Halmås in "Reference Pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment", published in the Journal of Public Economics in 2011 serves as the theoretical framework for this thesis. Brekke et al. discuss the competition between the branded and the generic pharmaceutical drugs in light of three regulatory settings: the price cap regulation, the exogenous reference price regulation and the endogenous reference price regulation. KEY FINDINGS Based on the literature review, price regulation has led to an average decrease of pharmaceutical prices and induced savings on pharmaceutical expenditures. Furthermore, price regulation seems to affect competitive strategies of pharmaceutical firms affecting launch, entry and R&D strategies. en
dc.format.extent 67
dc.language.iso en en
dc.title Pharmaceutical price regulation and competition en
dc.type G2 Pro gradu, diplomityö fi
dc.contributor.school Kauppakorkeakoulu fi
dc.contributor.school School of Business en
dc.contributor.department Department of Economics en
dc.contributor.department Taloustieteen laitos fi
dc.subject.keyword drugs
dc.subject.keyword lääkkeet
dc.subject.keyword regulations
dc.subject.keyword säädökset
dc.subject.keyword competition
dc.subject.keyword kilpailu
dc.identifier.urn URN:NBN:fi:aalto-201306267055
dc.type.dcmitype text en
dc.programme.major Economics en
dc.programme.major Kansantaloustiede fi
dc.type.ontasot Master's thesis en
dc.type.ontasot Pro gradu tutkielma fi
dc.subject.helecon kansantaloustiede
dc.subject.helecon economics
dc.subject.helecon hinnat
dc.subject.helecon prices
dc.subject.helecon kilpailu
dc.subject.helecon competition
dc.subject.helecon valvonta
dc.subject.helecon control
dc.subject.helecon lääketeollisuus
dc.subject.helecon pharmaceutical industry
dc.subject.helecon lääkkeet
dc.subject.helecon drugs
dc.subject.helecon terveystalous
dc.subject.helecon health economics
dc.ethesisid 13197
dc.date.dateaccepted 2013-02-05
dc.location P1 I


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search archive


Advanced Search

article-iconSubmit a publication

Browse

My Account